A phase Ib, open-label, dose-escalation trial of naptumomab estafenatox (Nap) in combination with durvalumab (MEDI4736) in subjects with selected advanced or metastatic solid tumor... von Geva, Ravit, Maurice-Dror, Corinne, Moskovitz, Mor Tal, Ben-Ami, Eitan, Raphael, Ari, Lorber, Ilana, Rozencweig, Marcel, Golan, Talia

Volltext

Abstract CT205: Safety and preliminary activity of naptumomab estafenatox (NAP) and durvalumab in patients with advanced or metastatic solid tumors: interim results from a phase 1b... von Geva, Ravit, Stemmer, Salomon, Perets, Ruth, Maurice-Dror, Corinne, Ben-Ami, Eitan, Raphael, Ari, Kumar, Sanjeev, Lorber, Ilana, Kedem, Tal Hetzroni, Fields, Scott Z., Rozencweig, Marcel, Golan, Talia

Volltext

ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME von FISHMAN, PNINA, LORBER, ILANA, COHN, ILAN, REITBLAT, TATIANA

Volltext bestellen

ADENOSIN-A3-RECEPTOR-AGONISTER TIL BEHANDLING AF SYGDOMME FORBUNDET MEDTØRRE ØJNE, HERUNDER SJÖGRENS SYNDROM von FISHMAN, PNINA, LORBER, ILANA, COHN, ILAN, REITBLAT, TATIANA

Volltext bestellen

ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME von FISHMAN, PNINA, LORBER, ILANA, COHN, ILAN, REITBLAT, TATIANA

Volltext bestellen

ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME von FISHMAN, PNINA, LORBER, ILANA, COHN, ILAN, REITBLAT, TATIANA

Volltext bestellen

Agonistas del receptor de adenosina A3 para el tratamiento de trastornos del ojo seco, incluido el síndrome de Sjogren von FISHMAN, PNINA, LORBER, ILANA, COHN, ILAN, REITBLAT, TATIANA

Volltext bestellen

ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME von FISHMAN, PNINA, LORBER, ILANA, COHN, ILAN, REITBLAT, TATIANA

Volltext bestellen